Johnson & Johnson
JNJ | NYSE
$269.47
-$0.52 (-0.19%)
At close: Sep 21, 2026, 4:00 PM ET
$268.35
-$1.12 (-0.42%)
Pre-market:
Sep 22, 2026, 5:36 AM ET
Fiscal Year Period Ending | FY 2025 Dec 27, 2025 | FY 2024 Dec 28, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Jan 1, 2022 | FY 2020 Jan 2, 2021 |
|---|---|---|---|---|---|---|
Revenue | 94.19B | 88.82B | 85.16B | 79.99B | 78.74B | 82.58B |
Cost of Revenue | 25.64B | 27.47B | 26.55B | 24.6B | 23.4B | 28.43B |
Gross Profit | 68.56B | 61.35B | 58.61B | 55.39B | 55.34B | 54.16B |
Operating Income | 25.6B | 22.15B | 23.41B | 21.01B | 20.94B | 19.73B |
Interest Income | 1.06B | 1.33B | 1.26B | 490M | 53M | 111M |
Pretax Income | 32.58B | 16.69B | 15.06B | 19.36B | 19.18B | 16.5B |
Net Income | 26.8B | 14.07B | 35.15B | 17.94B | 20.88B | 14.71B |
Selling & General & Admin | 23.68B | 21.97B | 20.11B | 20.25B | 20.12B | 22.08B |
Research & Development | 14.67B | 17.23B | 15.09B | 14.14B | 14.28B | 12.34B |
Other Expenses | 4.62B | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42.96B | 39.2B | 35.2B | 34.38B | 34.4B | 34.42B |
Interest Expense | 971M | 755M | 772M | 276M | 183M | 201M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 68.6B | 66.67B | 61.75B | 58.98B | 57.8B | 62.85B |
Income Tax Expense | 5.78B | 2.62B | 1.74B | 2.99B | 1.38B | 1.78B |
Shares Outstanding (Basic) | 2.43B | 2.41B | 2.53B | 2.61B | 2.63B | 2.63B |
Shares Outstanding (Diluted) | 2.43B | 2.43B | 2.56B | 2.66B | 2.67B | 2.67B |
EPS (Basic) | 11.03 | 5.84 | 13.88 | 6.83 | 7.93 | 5.59 |
EPS (Diluted) | 11.03 | 5.79 | 13.72 | 6.73 | 7.81 | 5.51 |
EBITDA | 41.06B | 24.78B | 23.32B | 26.61B | 26.75B | 23.93B |
EBIT | 33.55B | 17.44B | 15.83B | 19.64B | 19.36B | 16.7B |
Depreciation & Amortization | 7.5B | 7.34B | 7.49B | 6.97B | 7.39B | 7.23B |
Add to Watchlist
Select watchlists to add or remove JNJ